Relapsed/Refractory Non-Hodgkin Lymphoma
5 clinical trials · Condition
◉ Watch Relapsed/Refractory Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study (NCT03403725) | Menarini Group | 2017-08-28 |
Track Relapsed/Refractory Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.